REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems

HUS Group

Published: Aug 14, 2026

Updated: Aug 14, 2026

Source: hilma_fi

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Hospitals, Medical Equipment and Security Services. Located in Finland, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before February 14, 2027.

Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This is an advance notice — the formal tender is expected to be published shortly. Interested parties can use this time to prepare documentation and identify potential partners.

Description

REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems Helsinki University Hospital (HUS) and HUS Procurement is currently exploring solutions related to osseointegrated implant systems for patients with upper and/or lower limb loss. The purpose of this Request for Information (RFI) is to obtain information on products currently available on the market, their technical and clinical characteristics, implementation requirements, and supplier capabilities. The information obtained through this RFI will be used to increase HUS's understanding of the market and to support the planning of a potential future procurement process. SUBJECT OF THE MARKET DIALOGIA AND THE SOLUTION MAY INCLUDE: Intramedullary osseointegrated implants. Implant fixation components and connecting elements. Transcutaneous or equivalent prosthetic attachment systems. Surgical instruments and implantation equipment. Accessories and supporting products required for clinical use. Digital solutions, monitoring tools, or software related to the implant system, where applicable. Training, clinical support, and implementation services. The implant system should be intended to provide direct skeletal attachment of an external prosthesis as an alternative to conventional socket-based prosthetic solutions. SUPPLIERS ARE INVITATED TO PROVIDE INFORMATION ON THE FOLLOWING TOPICS: Company Information; name and contact details. Experience with osseointegrated implant systems. Product Information; name and commercial designation. Intended use and clinical indications. Description of the implant system and its main components. Available implant sizes, versions, and configurations. Materials used in the implant and connection components. Compatibility with external prosthetic systems. Clinical Evidence, available clinical studies and scientific publications, survival rates, complication rates, and long-term outcomes. References from hospitals currently using the system. Regulatory Information with certifications; CE marking status, Compliance with applicable European Union regulations. Surgical training requirements. Training programs for surgeons and clinical staff. Technical support and customer service. Guidance for patient follow-up and rehabilitation. Logistics and Commercial Information Product availability within Europe. Typical lead times. Product lifecycle expectations. Availability of spare parts and accessories. Information on maintenance, upgrades, and product development plans. MARKET DIALOGUE MEETING HUS procurement may invite selected suppliers to participate in a market dialogue meeting. The purpose of the discussions is to obtain further information regarding available solutions and market capabilities. Meetings may be arranged remotely via Microsoft Teams. DISCLAIMER This Request for Information is a preliminary market consultation and information-gathering exercise only. Participation in this RFI or any subsequent market dialogue does not create any obligation for HUS to initiate a procurement procedure, award a contract, or compensate suppliers for any costs incurred in preparing responses or participating in discussions. Neither the request for information nor its replies are binding on either party. Responding to a request for information does not affect the position of the tenderer in the forthcoming tender. The information provided by suppliers may be used solely for planning and preparing a potential future procurement process in accordance with applicable procurement legislation. SUBMISSION INSTRUCTIONS Suppliers are requested to submit their responses electronically in English. Responses should include all relevant supporting documentation, including product brochures, technical specifications, clinical evidence, and regulatory documentation where available. Answers should be submitted by 31.08.2026 12:00 GMT+2 at the latest to the email address: kilpailutus.kirurgia@hus.fi. The title or message field of the e-mail should mention: HUS 364-2026 Ortopediset Osseointegroitavat yläraajaimplantit., Lot 1: REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems Helsinki University Hospital (HUS) and HUS Procurement is currently exploring solutions related to osseointegrated implant systems for patients with upper and/or lower limb loss. The purpose of this Request for Information (RFI) is to obtain information on products currently available on the market, their technical and clinical characteristics, implementation requirements, and supplier capabilities. The information obtained through this RFI will be used to increase HUS's understanding of the market and to support the planning of a potential future procurement process. SUBJECT OF THE MARKET DIALOGIA AND THE SOLUTION MAY INCLUDE: Intramedullary osseointegrated implants. Implant fixation components and connecting elements. Transcutaneous or equivalent prosthetic attachment systems. Surgical instruments and implantation equipment. Accessories and supporting products required for clinical use. Digital solutions, monitoring tools, or software related to the implant system, where applicable. Training, clinical support, and implementation services. The implant system should be intended to provide direct skeletal attachment of an external prosthesis as an alternative to conventional socket-based prosthetic solutions. SUPPLIERS ARE INVITATED TO PROVIDE INFORMATION ON THE FOLLOWING TOPICS: Company Information; name and contact details. Experience with osseointegrated implant systems. Product Information; name and commercial designation. Intended use and clinical indications. Description of the implant system and its main components. Available implant sizes, versions, and configurations. Materials used in the implant and connection components. Compatibility with external prosthetic systems. Clinical Evidence, available clinical studies and scientific publications, survival rates, complication rates, and long-term outcomes. References from hospitals currently using the system. Regulatory Information with certifications; CE marking status, Compliance with applicable European Union regulations. Surgical training requirements. Training programs for surgeons and clinical staff. Technical support and customer service. Guidance for patient follow-up and rehabilitation. Logistics and Commercial Information Product availability within Europe. Typical lead times. Product lifecycle expectations. Availability of spare parts and accessories. Information on maintenance, upgrades, and product development plans. MARKET DIALOGUE MEETING HUS procurement may invite selected suppliers to participate in a market dialogue meeting. The purpose of the discussions is to obtain further information regarding available solutions and market capabilities. Meetings may be arranged remotely via Microsoft Teams. DISCLAIMER This Request for Information is a preliminary market consultation and information-gathering exercise only. Participation in this RFI or any subsequent market dialogue does not create any obligation for HUS to initiate a procurement procedure, award a contract, or compensate suppliers for any costs incurred in preparing responses or participating in discussions. Neither the request for information nor its replies are binding on either party. Responding to a request for information does not affect the position of the tenderer in the forthcoming tender. The information provided by suppliers may be used solely for planning and preparing a potential future procurement process in accordance with applicable procurement legislation. SUBMISSION INSTRUCTIONS Suppliers are requested to submit their responses electronically in English. Responses should include all relevant supporting documentation, including product brochures, technical specifications, clinical evidence, and regulatory documentation where available. Answers should be submitted by 31.08.2026 12:00 GMT+2 at the latest to the email address: kilpailutus.kirurgia@hus.fi. The title or message field of the e-mail should mention: HUS 364-2026 Ortopediset Osseointegroitavat yläraajaimplantit. CPV: 33000000 Organisation: HUS Group Documents: https://tarjouspalvelu.fi/huslogistiikka?id=623738&tpk=baa4d325-0199-4e29-b33f-6a7f224b96ac

Data provenance

This notice is sourced from Hilma Finland and was originally published on August 14, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About HUS Group

HUS Group has issued 40 procurement notices on BidsFactory, including 13 currently open and 12 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and Information & Communication Technology. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: August 14, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is February 14, 2027. You have 184 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by HUS Group in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.